AGP Picks
View all

Health & Wellness Today New York: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health & Wellness Today New York.

Press releases published on October 5, 2026

Lento Bio to Present Updates on LB-01, its Lens Flexibility Restoring Eye Drop for Presbyopia, at Eyecelerator 2026
New York State Department of Veterans’ Services Puts Women Veterans’ Health at the Center of October 20 Virtual Program
NAKA Welcomes George Wiemer as Vice President of Technical Services as Company Expands Nationwide
KSMModel.ai and PeptideDoc Launch 90-Day AI Visibility Study for Healthcare
Companies Listed Worldwide Present Live and Meet Investors at The Global Markets Forum (Hybrid), October 7 and 8
Kubbco releases new controversial new breast-health film
Brookbush Institute Publishes: 'What an 'Accredited' Personal Trainer Certification Really Means'
Spiritual Care Association Announces New Foundational Paper and Certification for Spiritual Care Nursing
Happy Health Becomes First Company to Receive FDA Clearance for Cuffless, Calibrationless Blood Pressure Measurement
BioTissue Appoints Rocco Venezia, CPA, as Chief Financial Officer
Enduraphin Named Official Protein Partner of Rochester Institute of Technology (RIT) Athletics
Legacy Opens Acres Homes Clinic to Expand Access to Care in a Historic Houston Community
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Remedora Adds Controlled Substance Prescribing to Its Telehealth Platform
Citizens Commission on Human Rights International: Mental Health Awareness Week Is Not Awareness When Forced Treatment Goes Unchallenged
Vaxcyte Announces Commencement of Proposed Public Offerings of Common Stock, Pre-Funded Warrants and Convertible Senior Notes
Aligos Therapeutics Announces Five Abstracts Accepted for Presentation at The Liver Meeting® 2026
Inspire Medical Systems, Inc. to Report Third Quarter 2026 Financial Results on November 2, 2026
Alamar Biosciences Names Former Grail CEO Bob Ragusa to Board of Directors and Expands Leadership Team
Korro Announces First Cohort Dosed in Phase 1/2 Clinical Trial (ANCHOR) for KRRO-121

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Health & Wellness Today New York

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.